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INTRODUCTION 
Spinal Cord Injury is one of the main pathologies that affect the central nervous system. It can 
be produced due to a traumatic experience, and generally disrupts the flow of the nerve impulse 
through the organism, resulting in a lack of nervous functions such as the motor function or 
sensitivity. Currently there is no available therapy that reverts the severe symptoms of the injury, 
so medical efforts are focused on searching a cure for the disease. 
 Stem Cells are a population of undifferentiated cells capable to differentiate into several 
different kinds of cells and proliferate, so their regenerative capacity to restore anatomic 
structures damaged has opened a new way to treat these injuries.  
This assay is a review of the current state of the research using all kind of stem cells in order to 
improve life quality of patient suffering from SCI. 
MATERIAL AND METHODS 
For the realization of this study it has been made an intense research in the database clinicaltrials.gov, run by the National Institute of Health, that includes the main clinical trials  that are 
being performed, as well as  in the main electronic  tools  that store scientific articles. In addition, an expert has been interviewed, doctor Joan Vidal Samsó, Head of Spinal Cord Injury Unit 
in Guttman Institute, to a better understanding of future perspectives. 
RESULTS 
In Vitro Studies Clinical Trials 
CONCLUSIONS 
In Vitro research with stem cells is focusing on 
organogenesis, in this case in developing complete 
spinal cord structures  using stem cells. For the 
moment, just small goals have been achieved and the 
development of complete cords seems quite far. 
Embryonic stem cells have been differentiated into 
neuromesodermal progenitors and previous forms of 
spinal cord development as neural cyst or spinal 
cavities. 
A lot of Clinical Trials are been carried out nowadays. 
The most part of them involve transplant of adult 
stem cells (specially mesenchymal and neural) to 
injured patients, and have just achieved phases I/II. 
They seem to be a secure procedure but with very 
small improvements on motor and sensory function.  










Until now, just adult stem cells (saving a few lines of embryonic stem cells well differentiated and characterized) 
seem to be close to medical application on spinal cord recovery. These trials are on initial phases and in spite of 
been safe therapies, in any case they reach a complete cure. In experts opinion, stem cells may promote new 
strategies to fight against motor and sensitive dysfunction, but they won’t get full recovery of the injury by their 
own: it will be necessary an integration of regenerative medicine, rehabilitation programs and pharmacological 
therapies to improve patients’ life quality. 
Adult stem cells’ reduced regeneration capability  is one of the major 
barriers on developing a good regenerative medicine strategy. On the 
other hand, iPSCs are as safe as adult stem cells, but in addition they 
include a great differentiation and proliferative profile. Due to this, iPSCs 
seem to be the technique that will reach a better spinal cord 
regeneration. 
Fig 1. Healthy, Injured and Recovered after Cell Treatment Spinal Cord [1] 
iPSCs Studies 
Just preclinical studies with iPSCs transplants to 
animals have been performed. iPSCs- derived cells 
show better results than adult stem cells on motor 
function recovery. 
Fig3. Cyst formation from ESCs. It’s shown 
the expressions of some markers of stem 
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Fig 4. Functional recovery after iPSCs-derived 
neurospheres transplant gets similar values 
compared to ES-derived neurospheres [4] 
Fig 5. Future strategies include the creation of 
iPSC stocks from healthy donors for spinal cord 
transplant in humans [5] 
Table 1. Main clinical trials using stem cells for SCI 
treatment. Amount of trials is shown in brackets. 
Data collected from clinicaltrials.gov 
 Stem Cell Kind Injury Level Time After Injury 
Bone Marrow Stem Cells (16) Cervical (5) Acute (1) 
Thoracic (3) Chronic (5) 
Unknown (8) Unknown (10) 
Neural Stem Cells (5) Cervical (1) Acute (1) 
Thoracic (2) Chronic (2) 
Indifferent (1) Indifferent (1) 
Unknown (1) Unknown (1) 
Adipose Tissue Stem Cells (4) Unknown (4) Acute (1) 
Chronic (2) 
Unknown (1) 
Oligodendrocyte Precursors (ESCs 
derived) (1) 
Thoracic (1) Unknown (1) 
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